Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Liquid vs Freeze-dried Pergoveris in Healthy Women
NCT02317809Phase 1Completed
- Sponsor
- Merck KGaA
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of luteinizing hormone in anovulation (2 arms), sponsored by Merck KGaA. Primary endpoints: Area Under the Concentration-Time Curve From Zero to Last Quantifiable Concentration and Maximum Serum Concentration. Started Jan 2015; status: completed.
02
Drugs
luteinizing hormone
03
Conditions
anovulation
Beyond the preview
Go deeper on NCT02317809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317809.